# Tara Nazareth

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tara-nazareth/

## Facts

| Field | Value |
| --- | --- |
| Citations | 250 |
| Field | Multiple Sclerosis Research Studies |
| h-index | 9 |
| i10-index | 9 |
| Last Known Institution | Amgen (United States) |
| OpenAlex ID | https://openalex.org/A5004243138 |
| ORCID iD | 0000-0003-0777-2014 |
| Works | 34 |

## Researcher papers

- [Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey](https://scholariq.org/papers/relapse-prevalence-symptoms-and-health-care-engagement-patient-insights-from-the/)
- [Outcomes-Based Contracting Experience: Research Findings from U.S. and European Stakeholders](https://scholariq.org/papers/outcomes-based-contracting-experience-research-findings-from-u-s-and-european/)
- [Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a US Health Plan Population](https://scholariq.org/papers/treatment-effectiveness-for-resolution-of-multiple-sclerosis-relapse-in-a-us/)
- [Burden of illness among patients with fragile X syndrome (FXS): a Medicaid perspective](https://scholariq.org/papers/burden-of-illness-among-patients-with-fragile-x-syndrome-fxs-a-medicaid/)
- [Characterizing Outcomes and Unmet Needs Among Patients in the United States with Mild-to-Moderate Plaque Psoriasis Using Prescription Topicals](https://scholariq.org/papers/characterizing-outcomes-and-unmet-needs-among-patients-in-the-united-states-with/)
- [Patients with Idiopathic Membranous Nephropathy: A Real-World Clinical and Economic Analysis of U.S. Claims Data](https://scholariq.org/papers/patients-with-idiopathic-membranous-nephropathy-a-real-world-clinical-and/)
- [Costs and health care resource utilization among chronic obstructive pulmonary disease patients with newly acquired pneumonia](https://scholariq.org/papers/costs-and-health-care-resource-utilization-among-chronic-obstructive-pulmonary/)
- [Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review](https://scholariq.org/papers/persistency-medication-prescribing-patterns-and-medical-resource-use-associated/)
- [<p>Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials</p>](https://scholariq.org/papers/and-lt-p-and-gt-efficacy-safety-and-quality-of-life-of-treatments-for-acute/)
- [Hyperlipidemia Guideline Adherence and Association with Patient Gender](https://scholariq.org/papers/hyperlipidemia-guideline-adherence-and-association-with-patient-gender/)

## Researcher topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)
- [Pneumonia and Respiratory Infections](https://scholariq.org/topics/pneumonia-and-respiratory-infections/)

## Researcher university

- [Amgen (United States)](https://scholariq.org/institutions/amgen-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.